{{Rsnum
|rsid=6774280
|Chromosome=3
|position=6214310
|Orientation=plus
|GMAF=0.1621
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.9 | 24.1 | 75.0
| HCB | 0.0 | 7.4 | 92.6
| JPT | 0.0 | 2.7 | 97.3
| YRI | 2.0 | 29.9 | 68.0
| ASW | 3.5 | 33.3 | 63.2
| CHB | 0.0 | 7.4 | 92.6
| CHD | 0.0 | 14.8 | 85.2
| GIH | 2.0 | 36.4 | 61.6
| LWK | 1.9 | 50.5 | 47.7
| MEX | 8.8 | 43.9 | 47.4
| MKK | 3.2 | 25.6 | 71.2
| TSI | 3.0 | 28.0 | 69.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22491018
|Trait=None
|Title=Genome-wide association analysis implicates the involvement of eight loci with response to tocilizumab for the treatment of rheumatoid arthritis.
|RiskAllele=
|Pval=9E-7
|OR=5.5000
|ORtxt=None
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}